- Home
- OMH vs CELU Comparison
OMH vs CELU Comparison
Compare OMH & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- CELU
- Stock Information
- Founded
- OMH 2015
- CELU 2016
- Country
- OMH Singapore
- CELU United States
- Employees
- OMH N/A
- CELU N/A
- Industry
- OMH Real Estate
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- CELU Health Care
- Exchange
- OMH Nasdaq
- CELU Nasdaq
- Market Cap
- OMH 35.8M
- CELU 42.2M
- IPO Year
- OMH 2023
- CELU N/A
- Fundamental
- Price
- OMH $1.42
- CELU $2.48
- Analyst Decision
- OMH Hold
- CELU
- Analyst Count
- OMH 1
- CELU 0
- Target Price
- OMH N/A
- CELU N/A
- AVG Volume (30 Days)
- OMH 147.1K
- CELU 423.4K
- Earning Date
- OMH 07-25-2025
- CELU 05-08-2025
- Dividend Yield
- OMH N/A
- CELU N/A
- EPS Growth
- OMH N/A
- CELU N/A
- EPS
- OMH N/A
- CELU N/A
- Revenue
- OMH $7,976,578.00
- CELU $54,220,000.00
- Revenue This Year
- OMH $28.40
- CELU $23.29
- Revenue Next Year
- OMH $23.07
- CELU N/A
- P/E Ratio
- OMH N/A
- CELU N/A
- Revenue Growth
- OMH 117.53
- CELU 138.11
- 52 Week Low
- OMH $0.59
- CELU $1.00
- 52 Week High
- OMH $6.20
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- OMH 47.16
- CELU 66.94
- Support Level
- OMH $1.41
- CELU $1.82
- Resistance Level
- OMH $1.56
- CELU $2.11
- Average True Range (ATR)
- OMH 0.10
- CELU 0.18
- MACD
- OMH 0.03
- CELU 0.05
- Stochastic Oscillator
- OMH 63.90
- CELU 79.07
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.